Last reviewed · How we verify
Estrogen Product
Estrogen Product is a Small molecule drug developed by University of Colorado, Denver. It is currently FDA-approved. Also known as: Estrogen transdermal patch.
Estrogen is a small molecule hormone that has been studied in various clinical trials for conditions such as Polycystic Ovary Syndrome, Obstructive Sleep Apnea, and Neoplasms of the Breast. It has been used in combination with other treatments, including depot leuprolide and pioglitazone, as part of estrogen/progestin replacement therapy.
At a glance
| Generic name | Estrogen Product |
|---|---|
| Also known as | Estrogen transdermal patch |
| Sponsor | University of Colorado, Denver |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer (PHASE1)
- ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors (PHASE1, PHASE2)
- SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer
- A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer) (PHASE2)
- Smoking Cessation and Menstrual Cycle Phase (PHASE4)
- Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. (PHASE1, PHASE2)
- An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors (PHASE1)
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Estrogen Product CI brief — competitive landscape report
- Estrogen Product updates RSS · CI watch RSS
- University of Colorado, Denver portfolio CI
Frequently asked questions about Estrogen Product
What is Estrogen Product?
Who makes Estrogen Product?
Is Estrogen Product also known as anything else?
What development phase is Estrogen Product in?
Related
- Manufacturer: University of Colorado, Denver — full pipeline
- Also known as: Estrogen transdermal patch
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing